Vaccine Storage Packaging Market

Vaccine Storage Packaging Market was valued at USD 5.22 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a CAGR of 4.5% during the forecast period.

Global Vaccine Storage Packaging Market Overview

The vaccine storage packaging market comprises the design, production, and supply of specialized packaging solutions that ensure the safe storage, handling, and transportation of vaccines by maintaining required temperature ranges, protecting product integrity, and complying with regulatory standards. This includes primary packaging (such as vials, ampoules, and pre-filled syringes), secondary and tertiary packaging (such as cartons, insulated boxes, and bulk containers), as well as advanced cold chain packaging solutions (including passive and active temperature-controlled systems, smart packaging, and monitoring devices). The Vaccine Storage Packaging Market serves pharmaceutical manufacturers, healthcare providers, logistics companies, and global immunization programs, addressing the critical need to preserve vaccine efficacy throughout the entire supply chain, from production to administration.

Key Companies Insights

• Lineage, Inc. specializes in cold storage and logistics services and operates across multiple regions. Its key service offerings include cold storage warehousing, port-centric warehousing, automated warehousing, sustainable warehousing, supply chain engineering, temperature-controlled rail, and others.

• DB SCHENKER, a global logistics solutions provider, offers various services, including contract logistics, advanced logistics services, industry-specific solutions, and more. It operates across nearly 1,850 locations worldwide and has a network of 725 warehouses.To know about the Research Methodology :- Request Free Sample Report

Vaccine Storage Packaging Market Dynamics

Surging Cold Chain Logistics Demand Accelerating Vaccine Storage Packaging Market Growth
The Vaccine Storage Packaging Market has witnessed significant growth, primarily driven by the rising demand for cold chain logistics. This surge is largely attributed to the increasing distribution of temperature-sensitive vaccines, particularly during and after the COVID-19 pandemic. The introduction of mRNA-based vaccines, such as Pfizer-BioNTech’s Comirnaty (BNT162b2), which requires ultra-cold storage at -70°C, and Moderna’s mRNA-1273, which requires -20°C storage, has created an unprecedented demand for specialized ultra-cold storage packaging solutions.

• McKesson remained a key partner to the U.S. federal government’s Strategic National Stockpile in 2024, continuing to distribute vaccines that require strict temperature-controlled storage and packaging. Delivered approximately 400-500 million doses globally from 2023-2024, with increasing shipments of combination COVID + flu vaccines. With the approval of combined influenza and COVID-19 boosters, McKesson scaled up its cold chain infrastructure, integrating validated packaging systems to handle millions of temperature-sensitive doses across its extensive national distribution network. The company’s expertise in packaging validation and end-to-end supply chain management played a critical role in maintaining vaccine efficacy during transport.

In response, countries have continued to make substantial investments to strengthen their cold chain infrastructure. As of 2024, India’s Universal Immunization Program (UIP) has expanded its network to nearly 32,000 cold chain points, incorporating advanced temperature monitoring and solar-powered refrigeration units to support new vaccines, including malaria and HPV. In Africa, the Africa CDC, with support from Gavi, UNICEF, and other partners, implemented extensive cold chain upgrades between 2023 and 2024 across all 54 African nations to support routine immunization and malaria vaccine rollouts.

In the United States, federal and state governments continued to allocate funding throughout 2023 and 2024, with additional investments exceeding USD 2 billion to upgrade cold storage capacity, expand warehouse facilities, and modernize packaging systems for combination vaccines. This ongoing demand has driven continued business growth for key players in the Vaccine Storage Packaging Market. Softbox (UK) introduced its next-generation reusable shippers with enhanced phase-change materials in 2024 to reduce packaging waste, while Pelican BioThermal (USA) expanded its network of global service centers to support the increasing demand for sustainable, reusable packaging solutions. Meanwhile, Cryoport (USA) reported strong revenue growth in 2024, driven by expanded contracts for mRNA vaccine transport, cell therapy logistics, and advanced cold storage packaging services, building on its leadership in ultra-cold and cryogenic packaging solutions.

Vaccine Storage Packaging Market Segment Analysis

In 2025, the Product Type segment shows the highest demand for Vials and Prefillable Syringes. Vials remain widely used for vaccine storage and distribution due to their durability, compatibility with multiple vaccine formulations, and suitability for multi-dose packaging, which helps reduce overall distribution costs. Prefillable syringes are increasingly gaining popularity as they improve dosing accuracy, reduce contamination risks, and enhance convenience during mass vaccination programs. Other components such as vial closures and ampoules also play essential roles in maintaining sterility and product integrity. Insulated boxes are increasingly important for maintaining temperature stability during transportation and storage within cold chain systems.

Based on Type, Primary Packaging holds the highest demand in 2025 as it directly comes into contact with vaccines and ensures sterility, stability, and protection from contamination. Components such as vials, syringes, and ampoules are critical in preserving vaccine potency during storage and administration. Secondary packaging is also widely used to provide additional protection, labeling, and handling convenience during distribution. Meanwhile, tertiary packaging supports bulk transportation and logistics, particularly for global vaccine distribution networks. However, primary packaging remains the most crucial segment due to its direct role in safeguarding vaccine quality.

Vaccine Storage Packaging Market Regional Analysis

Based on Region, North America leads the global vaccine storage packaging market in 2025 due to its advanced healthcare infrastructure, strong pharmaceutical manufacturing base, and strict regulatory standards for vaccine safety and storage. The region also benefits from well-established cold chain logistics and high vaccine production capacity. Asia Pacific is experiencing significant growth driven by expanding vaccine manufacturing in countries such as China and India, increasing immunization programs, and improvements in healthcare infrastructure. Europe maintains stable demand due to strong pharmaceutical research and strict packaging standards. Meanwhile, Latin America and the Middle East & Africa show moderate growth as governments and healthcare organizations continue to strengthen vaccination programs and healthcare supply chains.

Vaccine Storage Packaging Market Scope: Inquire before buying

Vaccine Storage Packaging Market, By Region

North America (United States, Canada, and Mexico)
Europe (UK, France, Germany, Italy, Spain, Russia, Rest of Europe)
Asia Pacific (China, South Korea, Japan, India, Australia, Rest of Asia Pacific)
Middle East and Africa (South Africa, Saudi Arabia, UAE, Rest of the Middle East &Africa)
South America (Brazil, Argentina, Rest of South America)

Key Players /Competitor Profiles Covered in the Vaccine Storage Packaging Market Report from a Strategic Perspective.

1. Lineage Inc.
2. AmerisourceBergen Corporation
3. DHL
4. DB Schenker
5. Cardinal Logistics
6. McKesson Corporation
7. Thermo Fisher Scientific Inc.
8. PHCbi (Panasonic Healthcare Co. Ltd.)
9. American Biotech Supply
10. Arctiko
11. Nipro Corporation
12. Amcor Plc
13. AptarGroup Inc.
14. Aseptic Group
15. Becton Dickinson and Company
16. Blowkings
17. Corning Incorporated
18. CSafe Global
19. DWK Life Sciences
20. Fengchen Group
21. Gerresheimer AG
22. Romaco Group
23. Schott AG
24. Sealed Air Corporation
25. SGD Pharma
26. Shandong Province Medicinal Glass Co. Ltd.
27. Stevanato Group